Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs

被引:84
|
作者
Lee, Joo Ho
Park, Hye-Kyung
Heo, Jeong
Kim, Tae Oh
Kim, Gwang Ha
Kang, Dae Hwan
Song, Geun Am
Cho, Mong
Kim, Dae Sung [1 ]
Kim, Hwal Woong [2 ]
Lee, Chang Hun [2 ]
机构
[1] Pusan Natl Univ, Coll Med, Dept Neurol, Pusan, South Korea
[2] Pusan Natl Univ, Coll Med, Dept Pathol, Pusan, South Korea
关键词
drug hypersensitivity; celecoxib; ethambutol; myositis; Korea; female;
D O I
10.3346/jkms.2008.23.3.521
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome reflects a serious hypersensitivity reaction to drugs, characterized by skin rash, fever, lymph node enlargement, and internal organ involvement. So far, numerous drugs such as sulfonamides, phenobarbital, sulfasalazine, carbamazepine, and phenytoin have been reported to cause the DRESS syndrome. We report a case in a 29-yr-old female patient who had been on celecoxib and anti-tuberculosis drugs for one month to treat knee joint pain and pulmonary tuberculosis. Our patient's clinical manifestations included fever, lymphadenopathy, rash, hypereosinophilia, and visceral involvement (hepatitis and pneumonitis). During the corticosteroid administration for DRESS syndrome, swallowing difficulty with profound muscle weakness had developed. Our patient was diagnosed as DRESS syndrome with eosinophilic polymyositis by a histopathologic study. After complete resolution of all symptoms, patch tests were positive for both celecoxib and ethambutol. Although further investigations might be needed to confirm the causality, celecoxib and ethambutol can be added to the list of drugs as having the possibility of DRESS syndrome.
引用
收藏
页码:521 / 525
页数:5
相关论文
共 50 条
  • [1] DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) SYNDROME INDUCED BY ANTI-TUBERCULOSIS DRUGS PRESENTING AS ACUTE CHOLECYSTITIS: A CASE REPORT
    Arelis, I. C.
    Patrimonio, M. T.
    Tulio, A. F.
    Sonza, S. P.
    Juaneza, R. R.
    Latriz, J. R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A50 - A50
  • [2] DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) SYNDROME WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) TRIGGERED BY ANTI-TUBERCULOSIS (ANTI-TB) DRUGS
    Ginete, Joann Kathleen B.
    Santiaguel, Joel M.
    RESPIROLOGY, 2013, 18 : 174 - 174
  • [3] Drug Rash With Eosinophilia and Systemic Symptoms (DRESS Syndrome)
    Gordon, Justin S.
    Neyman, Kimberly M.
    Wells, Ryan D.
    Chen, Suephy C.
    CUTIS, 2012, 89 (04): : 180 - 182
  • [4] DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS Syndrome)
    Lobo, Ines
    Ferreira, Marcia
    Velho, Gloria
    Sanches, Madalena
    Selores, Manuela
    ACTA MEDICA PORTUGUESA, 2008, 21 (04): : 367 - 372
  • [5] Drug rash with eosinophilia and systemic symptoms (dress syndrome)
    Tas, S
    Simonart, T
    ACTA CLINICA BELGICA, 1999, 54 (04) : 197 - 200
  • [6] Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Induced by Imatinib
    Zgolli, F.
    Aouinti, I
    Charfi, O.
    Badri, T.
    Elaidli, S.
    Kastalli, S.
    Lakhoua, G.
    Zaiem, A.
    CURRENT DRUG SAFETY, 2019, 14 (02) : 151 - 154
  • [7] Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir
    Keohane, C.
    Bacon, C. L.
    Moran, B.
    Irvine, A. D.
    Smith, O. P.
    PEDIATRIC TRANSPLANTATION, 2011, 15 (01) : 121 - 121
  • [8] Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome and tuberculosis: case report
    Montecchiani, V
    Zurbano Azqueta, L.
    De Las Vecillas Sanches, L.
    Anton, M.
    ALLERGY, 2017, 72 : 694 - 694
  • [9] DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) SYNDROME
    Kodela, Jennifer
    Lakshmanan, Srividhya
    Keyhanian, Kiandokht
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S506 - S507
  • [10] Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by imatinib
    Zgolli, F.
    Zaiem, A.
    Ben Salem, F.
    Aouinti, I.
    Charfi, O.
    Daghfous, R.
    Sihem, E. Aidli
    Sarrah, K.
    DRUG SAFETY, 2017, 40 (10) : 1006 - 1006